TrialViruses2021

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection.

Federico Gobbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.